Cardiovascular Risk and Resilience Among Black Adults: Rationale and Design of the MECA Study

Shabatun J Islam, Jeong Hwan Kim, Matthew Topel, Chang Liu, Yi-An Ko, Mahasin S Mujahid, Mario Sims, Mohamed Mubasher, Kiran Ejaz, Jan Morgan-Billingslea, Kia Jones, Edmund K Waller, Dean Jones, Karan Uppal, Sandra B Dunbar, Priscilla Pemu, Viola Vaccarino, Charles D Searles, Peter Baltrus, Tené T Lewis, Arshed A Quyyumi, Herman Taylor, Shabatun J Islam, Jeong Hwan Kim, Matthew Topel, Chang Liu, Yi-An Ko, Mahasin S Mujahid, Mario Sims, Mohamed Mubasher, Kiran Ejaz, Jan Morgan-Billingslea, Kia Jones, Edmund K Waller, Dean Jones, Karan Uppal, Sandra B Dunbar, Priscilla Pemu, Viola Vaccarino, Charles D Searles, Peter Baltrus, Tené T Lewis, Arshed A Quyyumi, Herman Taylor

Abstract

Background Cardiovascular disease incidence, prevalence, morbidity, and mortality have declined in the past several decades; however, disparities persist among subsets of the population. Notably, blacks have not experienced the same improvements on the whole as whites. Furthermore, frequent reports of relatively poorer health statistics among the black population have led to a broad assumption that black race reliably predicts relatively poorer health outcomes. However, substantial intraethnic and intraracial heterogeneity exists; moreover, individuals with similar risk factors and environmental exposures are often known to experience vastly different cardiovascular health outcomes. Thus, some individuals have good outcomes even in the presence of cardiovascular risk factors, a concept known as resilience. Methods and Results The MECA (Morehouse-Emory Center for Health Equity) Study was designed to investigate the multilevel exposures that contribute to "resilience" in the face of risk for poor cardiovascular health among blacks in the greater Atlanta, GA, metropolitan area. We used census tract data to determine "at-risk" and "resilient" neighborhoods with high or low prevalence of cardiovascular morbidity and mortality, based on cardiovascular death, hospitalization, and emergency department visits for blacks. More than 1400 individuals from these census tracts assented to demographic, health, and psychosocial questionnaires administered through telephone surveys. Afterwards, ≈500 individuals were recruited to enroll in a clinical study, where risk biomarkers, such as oxidative stress, and inflammatory markers, endothelial progenitor cells, metabolomic and microRNA profiles, and subclinical vascular dysfunction were measured. In addition, comprehensive behavioral questionnaires were collected and ideal cardiovascular health metrics were assessed using the American Heart Association's Life Simple 7 measure. Last, 150 individuals with low Life Simple 7 were recruited and randomized to a behavioral mobile health (eHealth) plus health coach or eHealth only intervention and followed up for improvement. Conclusions The MECA Study is investigating socioenvironmental and individual behavioral measures that promote resilience to cardiovascular disease in blacks by assessing biological, functional, and molecular mechanisms. REGISTRATION URL: https://www.clini​caltr​ials.gov. Unique identifier: NCT03308812.

Keywords: cardiovascular disease prevention; disparities; race and ethnicity; risk factor.

Figures

Figure 1. Schematic of the overall design…
Figure 1. Schematic of the overall design of the MECA (Morehouse‐Emory Center for Health Equity) Study.
Figure 2. Study region of the MECA…
Figure 2. Study region of the MECA (Morehouse‐Emory Center for Health Equity) Study, demonstrating the Atlanta, GA, metropolitan area with 2010 census tract boundaries.
Resilient and at‐risk census tracts are shown, which were identified by the residual percentile method. An inset of the figure shows the location of the study region in the state of Georgia.22

References

    1. Benjamin EJ, Muntner P, Bittencourt MS. Heart disease and stroke statistics‐2019 update: a report from the American Heart Association. Circulation. 2019;139:e56–e528.
    1. Van Dyke M, Greer S, Odom E, Schieb L, Vaughan A, Kramer M, Casper M. Heart disease death rates among blacks and whites aged >/=35 years—United States, 1968–2015. MMWR Surveill Summ. 2018;67:1–11.
    1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–e171.
    1. Gillum RF. Frequency of attendance at religious services and cigarette smoking in American women and men: the Third National Health and Nutrition Examination Survey. Prev Med. 2005;41:607–613.
    1. Sims M, Diez‐Roux AV, Gebreab SY, Brenner A, Dubbert P, Wyatt S, Bruce M, Hickson D, Payne T, Taylor H. Perceived discrimination is associated with health behaviours among African‐Americans in the Jackson Heart Study. J Epidemiol Community Health. 2016;70:187–194.
    1. Arias E, Heron M, Xu J. United States Life Tables, 2014. Natl Vital Stat Rep. 2017;66:1–64.
    1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–e292.
    1. Garmezy N. Resilience and vulnerability to adverse developmental outcomes associated with poverty. Am Behav Sci. 1991;34:416–430.
    1. Luthar SS. Vulnerability and resilience: a study of high‐risk adolescents. Child Dev. 1991;62:600–616.
    1. Garmezy N. Stress, competence, and development: continuities in the study of schizophrenic adults, children vulnerable to psychopathology, and the search for stress‐resistant children. Am J Orthopsy. 1987;57:159–174.
    1. Irwin MR. Sleep and inflammation in resilient aging. Interface Focus. 2014;4:20140009.
    1. Vale LJ, Campanella TJ. The Resilient City: How Modern Cities Recover from Disaster. New York: Oxford University Press; 2005.
    1. Sanders AE, Lim S, Sohn W. Resilience to urban poverty: theoretical and empirical considerations for population health. Am J Public Health. 2008;98:1101–1106.
    1. Reich JW, Zautra AJ, Hall JS. Handbook of Adult Resilience. New York: Guilford Press; 2010.
    1. Kaup AR, Nettiksimmons J, Harris TB, Sink KM, Satterfield S, Metti AL, Ayonayon HN, Yaffe K; for the Health, Aging, and Body Composition (Health ABC) Study . Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults. JAMA Neurol. 2015;72:340–348.
    1. Brewer LC, Redmond N, Slusser JP, Scott CG, Chamberlain AM, Djousse L, Patten CA, Roger VL, Sims M. Stress and achievement of cardiovascular health metrics: the American Heart Association life's simple 7 in blacks of the Jackson Heart Study. J Am Heart Assoc. 2018;7:e008855 DOI: 10.1161/JAHA.118.008855.
    1. Diez Roux AV, Merkin SS, Arnett D, Chambless L, Massing M, Nieto FJ, Sorlie P, Szklo M, Tyroler HA, Watson RL. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001;345:99–106.
    1. Clark CR, Ommerborn MJ, Hickson DA, Grooms KN, Sims M, Taylor HA, Albert MA. Neighborhood disadvantage, neighborhood safety and cardiometabolic risk factors in African Americans: biosocial associations in the Jackson Heart study. PLoS One. 2013;8:e63254.
    1. Borrell LN, Diez Roux AV, Rose K, Catellier D, Clark BL. Neighbourhood characteristics and mortality in the Atherosclerosis Risk in Communities Study. Int J Epidemiol. 2004;33:398–407.
    1. Fry‐Johnson YW, Levine R, Rowley D Agboto V, Rust G. United States black:white infant mortality disparities are not inevitable: identification of community resilience independent of socioeconomic status. Ethn Dis. 2010;20:S1–S131‐5.
    1. Topel Matthew L, Kim Jeong H, Mujahid Mahasin S, Ko YA, Vaccarino V, Mubasher M, Liu C, Dunbar S, Sims M, Taylor Herman A, et al. Individual characteristics of resilience are associated with lower‐than‐expected neighborhood rates of cardiovascular disease in blacks: results from the morehouse‐emory cardiovascular (MECA) center for health equity study.. J Am Heart Assoc. 2019;8:e011633 DOI: 10.1161/JAHA.118.011633.
    1. Kim JH, Lewis TT, Topel ML, Mubasher M, Li C, Vaccarino V, Mujahid MS, Sims M, Quyyumi AA, Taylor HA Jr, et al. Identification of resilient and at‐risk neighborhoods for cardiovascular disease among black residents: the morehouse‐emory cardiovascular (MECA) center for health equity study. Prev Chron Dis. 2019;16:E57.
    1. Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self‐management program on patients with chronic disease. Eff Clin Pract. 2001;4:256–262.
    1. Lloyd‐Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, et al. Executive summary: heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121:948–954.
    1. Lloyd‐Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613.
    1. Unger E, Diez‐Roux AV, Lloyd‐Jones DM, Mujahid MS, Nettleton JA, Bertoni A, Badon SE, Ning H, Allen NB. Association of neighborhood characteristics with cardiovascular health in the multi‐ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes. 2014;7:524–531.
    1. Mujahid MS, Diez Roux AV, Morenoff JD, Raghunathan T. Assessing the measurement properties of neighborhood scales: from psychometrics to ecometrics. Am J Epidemiol. 2007;165:858–867.
    1. Mujahid MS, Diez Roux AV, Cooper RC, Shea S, Williams DR. Neighborhood stressors and race/ethnic differences in hypertension prevalence (the Multi‐Ethnic Study of Atherosclerosis). Am J Hypertens. 2011;24:187–193.
    1. Segerstrom SC, Evans DR, Eisenlohr‐Moul TA. Optimism and pessimism dimensions in the Life Orientation Test‐Revised: method and meaning. J Res Pers. 2011;45:126–129.
    1. Ryff CD. Psychological well‐being revisited: advances in the science and practice of eudaimonia. Psychother Psychosom. 2014;83:10–28.
    1. Connor KM, Davidson JRT. Development of a new resilience scale: the Connor‐Davidson Resilience Scale (CD‐RISC). Depress Anxiety. 2003;18:76–82.
    1. Underwood LG, Teresi JA. The daily spiritual experience scale: development, theoretical description, reliability, exploratory factor analysis, and preliminary construct validity using health‐related data. Ann Behav Med. 2002;24:22–33.
    1. Krieger N, Smith K, Naishadham D, Hartman C, Barbeau EM. Experiences of discrimination: validity and reliability of a self‐report measure for population health research on racism and health. Soc Sci Med. 2005;61:1576–1596.
    1. Dozois DJA, Dobson KS, Ahnberg JL. A psychometric evaluation of the Beck Depression Inventory–II. Psychol Assess. 1998;10:83–89.
    1. Bremner JD, Vermetten E, Mazure CM. Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the early trauma inventory. Depress Anxiety. 2000;12:1–12.
    1. Buysse DJ, Reynolds CF III, Fau‐Monk TH, Monk TH, Berman SR, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–218.
    1. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91:7A–11A.
    1. Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper WC, Vaccarino V, Alexander RW, Harrison DG, Quyyumi AA. Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults. Hypertension. 2008;52:80–85.
    1. Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper WC, Vaccarino V, Harrison DG, Quyyumi AA. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol. 2006;47:1005–1011.
    1. Go YM, Jones DP. Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation. 2005;111:2973–2980.
    1. Nkabyo YS, Ziegler TR, Gu LH, Watson WH, Jones DP. Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco‐2) cells. Am J Physiol Gastrointest Liver Physiol. 2002;283:G1352–G1359.
    1. Droge W. The plasma redox state and ageing. Ageing Res Rev. 2002;1:257–278.
    1. Samiec PS, Drews‐Botsch C, Flagg EW, Kurtz JC, Sternberg P Jr, Reed RL, Jones DP. Glutathione in human plasma: decline in association with aging, age‐related macular degeneration, and diabetes. Free Radic Biol Med. 1998;24:699–704.
    1. Ashfaq S, Beinart SC, Abramson JL, Rhodes SD, Jurkovitz C, Vaccarino V, Williams JK, Jones DP, Quyyumi AA, Weintraub WS, Harrison DG. Plasma glutathione redox state: a novel marker of oxidative stress, correlates with early atherosclerosis in humans. J Am Coll Cardiol. 2003;41(suppl A):293A–294A.
    1. Ghasemzadeh N, Patel RS, Eapen DJ, Veledar E, Al Kassem H, Manocha P, Khayata M, Zafari AM, Sperling L, Jones DP, Quyyumi AA. Oxidative stress is associated with increased pulmonary artery systolic pressure in humans. Hypertension. 2014;63:1270–1275.
    1. Patel RS, Al Mheid I, Morris AA, Ahmed Y, Kavtaradze N, Ali S, Dabhadkar K, Brigham K, Hooper WC, Alexander RW, et al. Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis. 2011;218:90–95.
    1. Jones DP, Liang Y. Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med. 2009;47:1329–1338.
    1. Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ. High‐sensitivity C‐reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62:397–408.
    1. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin‐6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767–1772.
    1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967.
    1. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000;105:71–77.
    1. Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med. 1998;105:32S–39S.
    1. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age‐related endothelial dysfunction. J Am Coll Cardiol. 2005;45:1441–1448.
    1. Scheubel RJ, Zorn H, Silber R‐E, Kuss O, Morawietz H, Holtz J, Simm A. Age‐dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2003;42:2073–2080.
    1. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103:2885–2890.
    1. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schachinger V, Dimmeler S, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE‐AMI): mechanistic insights from serial contrast‐enhanced magnetic resonance imaging. Circulation. 2003;108:2212–2218.
    1. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593–600.
    1. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106:2781–2786.
    1. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, et al. Endothelial progenitor cells during cerebrovascular disease. Stroke. 2005;36:151–153.
    1. Patel RS, Li Q, Ghasemzadeh N, Eapen DJ, Moss LD, Janjua AU, Manocha P, Al Kassem H, Veledar E, Samady H, et al. Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease. Circ Res. 2015;116:289–297.
    1. Zhou S‐S, Jin J‐P, Wang J‐Q, Zhang Z‐G, Freedman JH, Zheng Y, Cai L. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018;39:1073–1084.
    1. Jove M, Portero‐Otin M, Naudi A, Ferrer I, Pamplona R. Metabolomics of human brain aging and age‐related neurodegenerative diseases. J Neuropathol Exp Neurol. 2014;73:640–657.
    1. Roede JR, Uppal K, Park Y, Lee K, Tran V, Walker D, Strobel FH, Rhodes SL, Ritz B, Jones DP. Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study. PLoS One. 2013;8:e77629.
    1. Shah SH, Kraus WE, Newgard CB. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation. 2012;126:1110–1120.
    1. Uppal K, Walker DI, Liu K, Li S, Go Y‐M, Jones DP. Computational metabolomics: a framework for the million metabolome. Chem Res Toxicol. 2016;29:1956–1975.
    1. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009;37:D603–D610.
    1. Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, Westler WM, Eghbalnia HR, Sussman MR, Markley JL. Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol. 2008;26:162–164.
    1. Smith CA, O'Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G. METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005;27:747–751.
    1. Baker M. Metabolomics: from small molecules to big ideas. Nat Methods. 2011;8:117–121.
    1. Uppal K, Walker DI, Jones DP. xMSannotator: an R package for network‐based annotation of high‐resolution metabolomics data. Anal Chem. 2017;89:1063–1067.
    1. Li S, Park Y, Duraisingham S, Strobel FH, Khan N, Soltow QA, Jones DP, Pulendran B. Predicting network activity from high throughput metabolomics. PLoS Comput Biol. 2013;9:e1003123.
    1. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard‐Herman M, Herrington D. Guidelines for the ultrasound assessment of endothelial‐dependent flow‐mediated vasodilation of the brachial artery*1: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–265.
    1. Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KRA, Quyyumi AA. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653–658.
    1. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS; American Society of Echocardiography Carotid Intima‐Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima‐Media Thickness Task Force: endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21:93–111; quiz 189–190.
    1. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.
    1. Kvedar JC, Fogel AL, Elenko E, Zohar D. Digital medicine's march on chronic disease. Nat Biotechnol. 2016;34:239–246.
    1. Fox S. The social life of health information. Pew Research Center. 2011. . Accessed December 12, 2019.
    1. Christopher Gibbons M. Use of health information technology among racial and ethnic underserved communities. Perspect Health Inform Manage. 2011;8:1f.
    1. Barg FK, Weiner MG, Joseph S, Pandit K, Turner BJ. Qualitative analysis of peer coaches’ experiences with counseling African Americans about reducing heart disease risk. J Gen Intern Med. 2012;27:167–172.
    1. Zoellner J, Powers A, Avis‐Williams A, Ndirangu M, Strickland E, Yadrick K. Compliance and acceptability of maintaining a 6‐month pedometer diary in a rural, African American community‐based walking intervention. J Phys Activity Health. 2009;6:475–482.
    1. Mahar EA, Mou L, Hayek SS, Quyyumi AA, Waller EK. Flow cytometric data analysis of circulating progenitor cell stability. Data Brief. 2017;10:346–348.
    1. Samman Tahhan A, Hammadah M, Sandesara PB, Hayek SS, Kalogeropoulos AP, Alkhoder A, Mohamed Kelli H, Topel M, Ghasemzadeh N, Chivukula K, et al. Progenitor cells and clinical outcomes in patients with heart failure. Circ Heart Fail. 2017;10:e004106.
    1. Samman Tahhan AS, Hammadah M, Raad M, Almuwaqqat Z, Alkhoder A, Sandesara PB, Kelli H, Hayek SS, Kim JH, O'Neal WT, et al. Progenitor cells and clinical outcomes in patients with acute coronary syndromes. Circ Res. 2018;122:1565–1575.
    1. Topel ML, Hayek SS, Ko YA, Sandesara PB, Samman Tahhan A, Hesaroieh I, Mahar E, Martin GS, Waller EK, Quyyumi AA. Sex differences in circulating progenitor cells. J Am Heart Assoc. 2017;6:e006245 DOI: 10.1161/JAHA.117.006245.
    1. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106.
    1. Yu T, Park Y, Li S, Jones DP. Hybrid feature detection and information accumulation using high‐resolution LC‐MS metabolomics data. J Proteome Res. 2013;12:1419–1427.
    1. Uppal K, Soltow QA, Strobel FH, Pittard WS, Gernert KM, Yu T, Jones DP. xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large‐scale, non‐targeted metabolomics data. BMC Bioinformatics. 2013;14:15.
    1. Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0–a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012;40:W127–W133.
    1. Yu T, Park Y, Johnson JM, Jones DP. apLCMS–adaptive processing of high‐resolution LC/MS data. Bioinformatics. 2009;25:1930–1936.
    1. Yu T, Peng H. Quantification and deconvolution of asymmetric LC‐MS peaks using the bi‐Gaussian mixture model and statistical model selection. BMC Bioinformatics. 2010;11:559.
    1. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78:779–787.
    1. Yu T, Jones DP. Improving peak detection in high‐resolution LC/MS metabolomics data using preexisting knowledge and machine learning approach. Bioinformatics. 2014;30:2941–2948.
    1. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA‐mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics. 2009;25:1991–1993.
    1. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, Paraskevopoulou MD, Prionidis K, Dalamagas T, Hatzigeorgiou AG. DIANA miRPath vol 2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 2012;40:W498–W504.
    1. Xia J, Wishart DS. MSEA: a web‐based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res. 2010;38:W71–W77.
    1. Xia J, Wishart DS. Web‐based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc. 2011;6:743–760.
    1. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge‐based approach for interpreting genome‐wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–15550.
    1. Efron B, Tibshirani R. On testing the significance of sets of genes. Ann Appl Stat. 2007;1:107–129.
    1. Wu MC, Zhang L, Wang Z, Christiani DC, Lin X. Sparse linear discriminant analysis for simultaneous testing for the significance of a gene set/pathway and gene selection. Bioinformatics. 2009;25:1145–1151.
    1. Choi Y, Kendziorski C. Statistical methods for gene set co‐expression analysis. Bioinformatics. 2009;25:2780–2786.
    1. Yu T, Bai Y. Capturing changes in gene expression dynamics by gene set differential coordination analysis. Genomics. 2011;98:469–477.
    1. Pan W, Xie B, Shen X. Incorporating predictor network in penalized regression with application to microarray data. Biometrics. 2010;66:​474–484.
    1. Wei Z, Li H. A Markov random field model for network‐based analysis of genomic data. Bioinformatics. 2007;23:1537–1544.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅